Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Elexacaftor/tezacaftor/ivacaftor’s impact on Canadian healthcare spending

Elexacaftor/tezacaftor/ivacaftor’s impact on Canadian healthcare spending

Resource Type

CF Research News

Authors

Stephen E. Congly, Ranjani Somayaji, Michael D. Parkins, Christina S. Thornton

References

2025 Nov;24(6):1027-1030. doi: 10.1016/j.jcf.2025.10.004. Epub 2025 Oct 15.

Document

File JCF-D-25-00284R1_FINAL_Congly_26012026.docx [1]

Keywords

CFTR modulator [2]
Health economics [3]
Kaftrio [4]
Spending [5]
Trikafta [6]

Date

Saturday, November 22, 2025

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/elexacaftortezacaftorivacaftor%E2%80%99s-impact-canadian-healthcare

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-25-00284R1_FINAL_Congly_26012026.docx [2] https://www.ecfs.eu/research-article-keywords/cftr-modulator [3] https://www.ecfs.eu/research-article-keywords/health-economics [4] https://www.ecfs.eu/research-article-keywords/kaftrio [5] https://www.ecfs.eu/research-article-keywords/spending [6] https://www.ecfs.eu/research-article-keywords/trikafta [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines